TITLE

Study of the acute cardiovascular effects of several antihypertensive agents with the measurement of plasma catecholamines in mice

AUTHOR(S)
Tsunoda, Makoto; Yamagishi, Masanori; Imai, Kazuhiro; Yanagisawa, Teruyuki
PUB. DATE
June 2009
SOURCE
Analytical & Bioanalytical Chemistry;Jun2009, Vol. 394 Issue 4, p947
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
A highly sensitive determination method was established for catecholamines (norepinephrine (NE), epinephrine, and dopamine) with high-performance liquid chromatography-peroxyoxalate chemiluminescence reaction detection. In this study, the method was applied to mouse plasma, and it was determined that only 10 μl of mouse plasma was necessary for the selective and reproducible determination of catecholamines. Studies were then conducted in acute cardiovascular effects of sodium nitroprusside, nicardipine, captopril (angiotensin-converting enzyme (ACE) inhibitor), candesartan, and olmesartan (type 1 angiotensin receptor antagonists (AT1 antagonists)) by this method. Sodium nitroprusside and nicardipine elevated plasma NE concentrations significantly, whereas the ACE inhibitor and the AT1 antagonists did not change plasma NE concentrations in anesthetized mice. These results suggested that angiotensin II-induced augmentation may be mainly carried through the central baroreflex pathway.
ACCESSION #
39776243

 

Related Articles

  • Polymorphisms of angiotensinogen and angiotensin-converting enzyme associated with lower extremity arterial disease in the Health, Aging and Body Composition study. Li, R.; Nicklas, B.; Pahor, M.; Newman, A.; Sutton-Tyrrell, K.; Harris, T.; Lakatta, E.; Bauer, D. C.; Ding, J.; Satterfield, S.; Kritchevsky, S. B. // Journal of Human Hypertension;Aug2007, Vol. 21 Issue 8, p673 

    The role of renin–angiotensin system (RAS) genes on the risk of lower extremity arterial disease (LEAD) in elderly people remains unclear. We assessed the relationship of genetic polymorphisms in RAS: G-6A, T174M and M235T of the angiotensinogen (AGT) gene, and the angiotensin-converting...

  • Mechanism of the antihypertensive effect of K depletion in the spontaneously hypertensive rat. Linas, Stuart L.; Marzec-Calvert, Rochelle; Ullian, Michael E.; O'Brien, Richard F. // Kidney International;Jul1988, Vol. 34 Issue 1, p18 

    K depletion reverses hypertension in (he SHR (systolic blood pressure: K deplete 122 ± 5 vs. K replete 164 ± 4 mm Hg. P ≤ 0.001), To determine the role of the renin angiotensin system in the protective effect of K depletion, we performed studies of vascular reactivity in intact SHR...

  • Combinations of Renin-Angiotensin-Aldosterone System Antagonists: True Advantages?. Veglio, Franco; Puglisi, Elisabetta; Milan, Alberto; Mulatero, Paolo // Current Pharmaceutical Design;3/1/2012, Vol. 18 Issue 7, p952 

    The renin angiotensin aldosterone system (RAAS) inhibitors induce an incomplete blockade of the system at different steps. Recently, the dual RAAS therapy is emerging in clinical practice, although there is a lack of evidence on safety and efficacy for this combination in several cardiovascular...

  • Angiotensin-II receptor blockers: benefits beyond blood pressure reduction? Volpe, M; Ruilope, LM; McInnes, GT; Waeber, B; Weber, MA // Journal of Human Hypertension;May2005, Vol. 19 Issue 5, p331 

    Effective treatment of hypertension is essential to reduce the risk of renal and cardiovascular (CV) morbidity. The risks associated with hypertension are modulated by the presence of other factors. This has prompted the quest for agents that have benefits beyond blood pressure (BP) lowering....

  • Losartan more effective than atenolol in hypertension with left ventricular hypertrophy. Montgomery, Lynda // Journal of Family Practice;Jul2002, Vol. 51 Issue 7, p599 

    This article offers information on a study that examined patients suffering from hypertension with left ventricular hypertrophy. The development of left ventricular hypertrophy is associated with angiotensin II. Several people from the U.S. and Northern Europe with hypertension and...

  • Choice of Antihypertensive Treatment in Subjects with Pre-Diabetes. Is There a Dream After the Navigator. Eleftheriadou, Ioanna; Tsioufis, Costas; Tsiachris, Dimitrios; Tentolouris, Nicholas; Stefanadis, Christodoulos // Current Vascular Pharmacology;Nov2011, Vol. 9 Issue 6, p715 

    The majority of individuals with pre-diabetic states eventually appear to develop diabetes mellitus. During the pre-diabetic state, that may last many years, the risk of cardiovascular disease is modestly increased, with impaired glucose tolerance being slightly stronger predictor for future...

  • Aliskiren, a Direct Renin Inhibitor, in Clinical Practice: A New Approach in the Treatment of Hypertension. Moutzouri, Elisavet; Florentin, Matilda; Elisaf, Moses S.; Mikhailidis, Dimitri P.; Liberopoulos, Evangelos N. // Current Vascular Pharmacology;May2010, Vol. 8 Issue 3, p344 

    Objective: Arterial hypertension is an important risk factor for the development and progression of cardiovascular disease (CVD). The renin angiotensin aldosterone system (RAAS) plays a crucial role in the pathophysiology of hypertension and associated complications. Direct renin inhibitors...

  • Vascular and metabolic properties of manidipine. Ríos, N. Buset; Esparragón, F. Rodríguez; Rodríguez, C. Fernández-Andrade; Pérez, J. C. Rodríguez // Nefrologia;2011, Vol. 31 Issue 3, p268 

    The combination of renin-angiotensin system blockers with calcium channel blockers appears to be one of the most effective options for treating hypertension and diabetes. Nevertheless, not all calcium blockers behave in the same manner. Manidipine, unlike other third-generation dihydropyridine...

  • Cardiovascular Risk in Obese Hypertensive Patients Taking Various Antihypertensive Drugs. Schindler, Christoph; Bramlage, Peter; Thoenes, Martin; Bramlage, Carsten; Kirch, Wilhelm // Clinical Drug Investigation;2007, Vol. 27 Issue 10, p707 

    Objective: Obese patients often present with multiple co-morbid conditions, including hypertension, which are associated with an increased cardiovascular (CV) risk. We aimed to assess the risk factor profiles of primary-care patients with obesity and hypertension in order to estimate their fatal...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics